RETN and breast carcinoma: There is some supportive evidence from two studies using breast cancer tissue, one of which reported gene expression levels of resistin to be higher in triple negative breast tissue compared to luminal A subtype32 and the other found higher resistin expression (staining score > 50% of cells) to be associated with poorer overall survival independent of hormone receptor status31.